Pembrolizumab and radiation therapy for multifocal myxofibrosarcoma of the scalp: a case report

被引：0
作者：
Grant, Christopher Ryan [1 ]
Arter, Zhaohui [2 ]
Smith, Janellen [3 ]
Seyedin, Steven N. [4 ]
Nourbakhsh, Mahra [5 ]
Lee, Bonnie [3 ,5 ]
Creadore, Andrew [3 ]
Mar, Nataliya [2 ]
机构：
[1] Univ Calif Irvine, Med Ctr, Dept Med, 101 City Dr South, Orange, CA 92868 USA
[2] Univ Calif Irvine, Med Ctr, Div Hematol Oncol, Orange, CA USA
[3] Univ Calif Irvine, Med Ctr, Dept Dermatol, Orange, CA USA
[4] Univ Calif Irvine, Med Ctr, Dept Radiat Oncol, Orange, CA USA
[5] Univ Calif Irvine, Med Ctr, Dept Pathol, Orange, CA USA
来源：
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY | 2024年 / 16卷
关键词：
immune checkpoint inhibitor; myxofibrosarcoma; pembrolizumab; soft tissue sarcoma; SOFT-TISSUE SARCOMA; OPEN-LABEL; MULTICENTER; IMMUNOTHERAPY; CHEMOTHERAPY; PAZOPANIB; CANCER; GRADE;
D O I：
10.1177/17588359241259451
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Myxofibrosarcoma is one of the most common types of soft tissue sarcomas occurring in the lower limbs of male older adults. Mainstay treatment is surgical intervention with chemoradiotherapy with a combination of doxorubicin and ifosfamide with brachytherapy if advanced or metastatic. There are no guidelines on the combination of immunotherapy with radiation therapy for myxofibrosarcoma. We report the first documented case of unresectable multifocal myxofibrosarcoma that was treated with pembrolizumab and radiation therapy for first-line therapy with a significant response. We also highlight genomic markers and immune radiation priming therapy, forecasting favorable response in treatment with pembrolizumab.
引用
收藏
页数：9
相关论文
共 42 条
  • [1] [Anonymous], 2022, Sarcoma & GIST plus CUP | OncologyPRO
  • [2] [Anonymous], Study Details | ENVASARC: envafolimab and envafolimab with ipilimumab in patients with undifferentiated pleomorphic sarcoma or myxofibrosarcoma
  • [3] [Anonymous], 2020, WHO Classification of Tumours: Soft Tissue and Bone Tumours
  • [4] DNA mismatch repair in cancer
    Baretti, Marina
    Le, Dung T.
    [J]. PHARMACOLOGY & THERAPEUTICS, 2018, 189 : 45 - 62
  • [5] Immunotherapy with Single Agent Nivolumab for Advanced Leiomyosarcoma of the Uterus: Results of a Phase 2 Study
    Ben-Ami, Eytan
    Barysauskas, Constance M.
    Solomon, Sarah
    Tahlil, Kadija
    Malley, Rita
    Hohos, Melissa
    Polson, Kathleen
    Loucks, Margaret
    Severgnini, Mariano
    Patel, Tara
    Cunningham, Amy
    Rodig, Scott J.
    Hodi, F. Stephen
    Morgan, Jeffrey A.
    Merriam, Priscilla
    Wagner, Andrew J.
    Shapiro, Geoffrey I.
    George, Suzanne
    [J]. CANCER, 2017, 123 (17) : 3285 - 3290
  • [6] Brennan MF., 2016, Management of soft tissue sarcoma, P143, DOI [10.1007/978-3-319-41906-0_7, DOI 10.1007/978-3-319-41906-0_7]
  • [7] The Effect of Concurrent Stereotactic Body Radiation and Anti-PD-1 Therapy for Recurrent Metastatic Sarcoma
    Callaghan, Cameron M.
    Seyedin, Steven N.
    Mohiuddin, Imran H.
    Hawkes, Kelli L.
    Petronek, Michael S.
    Anderson, Carryn M.
    Buatti, John M.
    Milhem, Mohammed M.
    Monga, Varun
    Allen, Bryan G.
    [J]. RADIATION RESEARCH, 2020, 194 (02) : 124 - 132
  • [8] Chowdhary A., Cureus J Med Sci
  • [9] Activity of anthracycline- and ifosfamide-based chemotherapy in a series of patients affected by advanced myxofibrosarcoma
    Colia, Vittoria
    Fiore, Marco
    Provenzano, Salvatore
    Fumagalli, Elena
    Bertulli, Rossella
    Morosi, Carlo
    Dei Tos, Angelo P.
    Barisella, Marta
    Gronchi, Alessandro
    Casali, Paolo G.
    Sanfilippo, Roberta
    [J]. CLINICAL SARCOMA RESEARCH, 2017, 7
  • [10] Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial
    Demetri, George D.
    von Mehren, Margaret
    Jones, Robin L.
    Hensley, Martee L.
    Schuetze, Scott M.
    Staddon, Arthur
    Milhem, Mohammed
    Elias, Anthony
    Ganjoo, Kristen
    Tawbi, Hussein
    Van Tine, Brian A.
    Spira, Alexander
    Dean, Andrew
    Khokhar, Nushmia Z.
    Park, Youn Choi
    Knoblauch, Roland E.
    Parekh, Trilok V.
    Maki, Robert G.
    Patel, Shreyaskumar R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (08) : 786 - +
12345